After coronary drug-eluting stent placement, does a longer course of dual antiplatelet therapy lead to decreased thrombotic events? : Evidence-Based Practice

Secondary Logo

Journal Logo

Advanced Search
HELPDESK ANSWERS

After coronary drug-eluting stent placement, does a longer course of dual antiplatelet therapy lead to decreased thrombotic events?

Breen, James O. MD; Dimas, Kristen MD; Ferra, Danielle DO; Hart, Laura DO; Stephen, Stacy MD

Author Information

FSU/Lee Health Family Medicine Residency Program, 2780 Cleveland Avenue, Suite 709, Fort Myers, FL 33901

The corresponding author is James O. Breen; [email protected].

The authors declare no conflicts of interest.

Evidence-Based Practice 26(3):p 16-17, March 2023. | DOI: 10.1097/EBP.0000000000001812
Copyright © 2022 by Family Physicians Inquiries Network, Inc.

Full Text Access for Subscribers:

Not a Subscriber?

Buy
Request Permissions

You can read the full text of this article if you:

Access through Ovid